Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Injection Pen Market Growth in 2025?

Over the past few years, the market size of the injection pen has seen robust growth. Forecasts predict an increase from $57.05 billion in 2024 to $61.68 billion in 2025 maintaining a compound annual growth rate (CAGR) of 8.1%. This growth in the historic phase can be credited to the rising necessity for diabetes management, increased patient inclination, decline in needle phobia, enhancement in dosage precision, and growing elderly population.

What Is the Forecast for the Injection Pen Market Size Through 2029?

The market size of the injection pen is anticipated to witness substantial growth in the coming years, expanding to a whopping $95.12 billion by 2029. This presents a compound annual growth rate (CAGR) of 11.4%. This growth surge during the predicted period can be ascribed to factors like escalating diabetes cases, growth in biologics and biosimilars, mounting demand for customized medication, the necessity for home healthcare, and the rise of emerging markets. The major trends in the forecast period encompass smart injection pens, the integration of digital health, wearable tech, enhanced user interface, and compatibility with autoinjectors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5676&type=smp

What are the Key Market Players in Injection Pen Market and How They’re Evolving?

Major companies operating in the injection pen market include Novo Nordisk A/S, Ypsomed Holding AG, Sandoz Inc., Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Owen Mumford Ltd., Sulzer Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Ltd., Wockhardt Ltd., AptarGroup Inc., Novartis AG, Gerresheimer AG, SHL Medical AG, Boehringer Ingelheim International GmbH, Nemera France SA, Companion Medical Inc., Jiangsu Delfu Medical Devices Co. Ltd., Haselmeier GmbH, GlaxoSmithKline plc., Stat Medical Devices Inc., DuPont de Nemours Inc., Emperra GmbH E-Health Technologies, Biocon Limited, Becton Dickinson and Company, Mylan N.V., Terumo Corporation, West Pharmaceutical Services Inc., Bespak Europe Ltd., Mitsubishi Gas Chemical Company Inc., Nipro Corporation, Zogenix Inc., Consort Medical plc

What Are the Primary Growth Drivers in the Injection Pen Market?

The growing occurrence of illnesses like diabetes and arthritis is spurring the expansion of the injection pen market. The escalating number of obese individuals, lack of physical activity, unhealthy dietary habits, and an aging population have resulted in a rise in the global prevalence of diabetes. For example, according to the International Diabetes Federation (IDF), the worldwide diabetes prevalence population is anticipated to reach roughly 640 million by 2040. Additionally, it’s estimated that approximately 69 million individuals are diabetic in emerging countries like India. This figure is predicted to increase to 100 million by 2030. Consequently, the escalating incidence of illnesses like diabetes and arthritis will stimulate the growth of the injection pen market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5676&type=smp

What Are the Leading Segments in the Global Injection Pen Industry?

The injection pen market covered in this report is segmented –

1) By Product Type: Disposable Injection Pens, Reusable Injection Pens

2) By Therapy: Diabetes, Fertility, Osteoporosis, Growth Hormone Therapy, Other Therapies

3) By End Users: Home Care, Hospital And Clinics

Subsegments:

1) By Disposable Injection Pens: Pre-filled Disposable Injection Pens, Single-Use Disposable Injection Pens

2) By Reusable Injection Pens: Refillable Injection Pens, Multi-Use Injection Pens, Rechargeable Injection Pens

What Are the Key Market Trends in the Injection Pen Industry?

The rising trend of technological advancements is becoming significant in the injection pen market. The focus of the market entities in this domain is leaning heavily towards the innovation of products and optimized delivery systems. These advancements in technology offer precise delivery, increased patient satisfaction and compliance, along with enhanced convenience of use. For instance, Medtronic, a company based in the US providing medical technology, services, and solutions, introduced InPen integrated with real-time Guardian Connect CGM data in September 2022. This collective solution offers users a single screen display of all the needed information to manage their diabetes, including real-time glucose levels and insulin dosing details. Users find it easier to all, their information in real time on one screen as opposed to jumping between apps, making it more straightforward for them to decide the dosage required to keep their blood sugar levels under control.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/injection-pen-global-market-report

What Is the Regional Outlook for the Injection Pen Market?

North America was the largest region in the injection pen market in 2024. The regions covered in the injection pen market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5676

This Report Delivers Insight On:

1. How big is the injection pen market, and how is it changing globally?

2. Who are the major companies in the injection pen market, and how are they performing?

3. What are the key opportunities and risks in the injection pen market right now?

4. Which products or customer segments are growing the most in the injection pen market?

5. What factors are helping or slowing down the growth of the injection pen market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model